CLINICIAN RESOURCES
PPN maintains the most up to date clinical guidelines for PANDAS and PANS. Guidelines will always be based on published information and further refined and explained by the Diagnostics & Therapeutics Committee.
PPN Treatment Options aim to provide the breadth of potential therapies for PANDAS and PANS, updated for the latest research and experience of clinicians. There are a variety of treatment options available.
“Seeing Your First Child with PANDAS/PANS” is a medical guide consisting of: overview and current theories, PANS diagnostic criteria, PANS workup recommendations, and setting medical and family expectations.
The diagnostic flowchart and treatment guidelines include a detailed process provided for determining the appropriate diagnosis and symptom severity-based treatment protocols for mild, moderate, and severe/extreme cases.
FREE WEBINAR
Caregiver Coping with PANS/PANDAS
Caring for a loved one with PANS/PANDAS can result in high caregiver burden, symptoms of depression, anxiety, and post traumatic stress. Learn how to care for yourself and others in this webinar.
STUDY RECRUITING
Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
The investigators propose to systematically evaluate the effects of naproxen sodium on anti-obsessional and behavioral improvement in children with PANDAS.
LATEST RESEARCH
Evaluation of Intravenous Immunoglobulin in PANS
“In this population of PANS subjects, all psychometric endpoints studied exhibited statistically significant decreases following six infusions of IVIG…The durability of response is also noteworthy.”
LATEST RESEARCH
Cognitive, Graphomotor, and Psychosocial Challenges in PANDAS
“These findings indicated relative difficulties with aspects of executive and motor functions. Although evaluations were performed following the resolution of acute symptoms, ongoing and significant academic difficulties and emotional, behavioral, and social concerns were targets for clinical intervention and support.”
FRONTIERS IN PSYCHIATRY
Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and PANDAS
“Our results suggest that the panel of four antineuronal antibodies and CaMKII activation assays successfully identify acute illness in PANDAS, providing opportunities for rapid and accurate diagnosis and treatment.”
BECOME A MEMBER
BENEFITS
► Receive email alerts on new research, guidelines, and treatment protocols
► Option to be recognized as a practitioner who works with PANS/PANDAS patients
► Receive occasional members only benefits
PANS/PANDAS RESEARCH AND LITERATURE
OUR MISSION
The PPN mission is to maintain the industry standard PPN Guidelines for Diagnostics and Therapeutics, foster continuous education and communication within the multi-disciplinary medical community and to sponsor research for developing diagnostic tests, treatment protocols and a cure for PANDAS/PANS within this generation.
CHANGE THE COURSE OF MENTAL ILLNESS WITHIN A GENERATION
PPN’s goal is to help medical professionals understand, diagnose and treat PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) by providing to them quality research, diagnostic and treatment tools. Your donation dollars will not only help maintain PPN’s tools, but will help further prove that the immune system can cause such psychological distress.